Business
Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes
SAN DIEGO, May 05, 2026--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced its intention to offer, subject to market and other conditions, $400 million aggregate principal amount of convertible senior notes due 2032 (the "Notes") in an underwritten offering. Travere also expects to grant the underwriters of the Notes a 30-day option to purchase up to an additional $60 million aggregate principal amount of Notes, solely to cover over-allotments. As described in more detail below, Travere
About this update from Travere Therapeutics, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1604,"height":352,"url":"https://media.zenfs.com/en/business-wire.com/fc486e4275824d2cc52109f86d59bf15"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QpQM6yCT4nIMcPS3ZE8uiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIxMQ--/https://media.zenfs.com/en/business-wire.com/fc486e4275824d2cc52109f86d59bf15","width":960,"height":211},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/fsJk_LCtmUnFJFhMNPnN0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MjY-/https://media.zenfs.com/en/business-wire.com/fc486e4275824d2cc52109f86d59bf15","width":1200,"height":263}},"lazy":false},{"type":"text","content":"SAN DIEGO, May 05, 2026--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced its intention to offer, subject to market and other conditions, $400 million aggregate principal amount of convertible senior notes due 2032 (the "Notes") in an underwritten offering. Travere also expects to grant the underwriters of the Notes a 30-day option to purchase up to an additional $60 million aggregate principal amount of Notes, solely to cover over-allotments. As described in more detail below, Travere intends to use a portion of the net proceeds from the offering to repurchase a portion of its currently outstanding convertible notes.","length":661,"tagName":"p"},{"type":"text","content":"The Notes will be senior unsecured obligations of Travere and will accrue interest payable semiannually in arrears. The Notes will be convertible in certain circumstances into cash, shares of Travere’s common stock, or a combination of cash and shares of Travere’s common stock, at Travere’s election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of the pricing of the offering.","length":436,"tagName":"p"},{"type":"text","content":"Travere intends to use a portion of the net proceeds from the offering to repurchase a portion of its outstanding 2.25% senior convertible notes due 2029 (the "2029 Notes") for cash, depending on negotiations and pricing determinations in connection with such proposed repurchase transactions. Travere is negotiating these repurchases with certain of the holders of the 2029 Notes, and no assurance can be given as to how much,...